Mankind Pharma Expands into Analgesics with Launch of Nimulid Strong for Neck Pain Relief

Representation image

Mankind Pharma, a known name in India’s pharmaceutical industry, has entered the topical analgesic market through its consumer business division. The company has launched Nimulid Strong, an innovative gel and spray formulation specifically tailored to alleviate neck pain—a condition that can significantly disrupt daily activities.

Nimulid Strong’s standout feature is its 2X concentration of diclofenac, which promises quicker relief for those suffering from neck pain. This launch aligns with Mankind Pharma’s broader strategy to expand its consumer healthcare portfolio and address key pain management challenges.

To promote Nimulid Strong, the company has introduced a captivating video campaign titled #GardanHilaateRaho. The campaign, narrated in Hindi, emphasizes the cultural importance of neck movements in Indian communication.

It connects the idea of unrestricted neck movement with the effectiveness of Nimulid Strong in relieving neck pain. The campaign’s tagline, “Kaam Chalate Raho, Gardan Hilaate Raho,” highlights the product’s role in enabling uninterrupted daily activities.

The video creatively showcases different scenarios where neck movements are crucial for non-verbal communication, from expressing emotions to marking progress and celebrating national achievements. It underscores how Nimulid Strong, with its potent 2X diclofenac formulation, ensures that neck pain does not hinder these important interactions.

Also Read |  AOI at Citizens Hospital Saves 93-Year-Old with Advanced Colon Cancer

Joy Chatterjee, Vice President of Sales and Marketing for the Consumer Business Unit at Mankind Pharma Ltd remarked, “Our foray into the topical analgesic market with Nimulid Strong represents a significant milestone for Mankind Pharma’s consumer business. By focusing on neck pain, which can greatly impact daily life, we aim to empower millions of Indians to live and communicate more freely. Our innovative 2X diclofenac formulation, combined with a powerful video campaign, highlights the essential role of neck movements in everyday interactions. The campaign’s message, ‘Gardan dard ka specialist’ (Specialist in neck pain), positions Nimulid Strong as the preferred solution for this common yet significant issue”.

As reported by pharmabiz.com, Nimulid Strong will be available in both gel and spray forms, offering consumers versatility in application. The product is set to be distributed across pharmacies and modern trade outlets nationwide, supported by a comprehensive marketing campaign spanning multiple media channels.